For STMN2, the number of CEs detected in each C9ORF72 subgroup reflected the expected level of TDP-43 pathological burden in the frontal cortex, with C9-FTD tissues having the highest STMN2 CE counts and C9-ALS tissues having the lowest. This evidence concerns the gene TARDBP and frontotemporal dementia.